Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 431-440

  Rubins, Jeffrey B ^a   Puri, Amitab K G ^b   Loch, Joyce ^c   Charboneau, Darlene ^c   MacDonald, Rod ^c   Opstad, Nancy ^c   Janoff, Edward N ^c  

^a VA MEDICAL CENTER   (United States)

^b Green Valley Medical Center   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; PNU IMMUNE 23; UNCLASSIFIED DRUG;

AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OPSONIZATION; PRIORITY JOURNAL; QUALITY CONTROL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0031848921     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515644     Document Type: Article

References (19)

1. Kramer MR, Rudensky B, Hadas-Halperin I, Isacsohn M, Melzer E. Pneumococcal bacteremia - no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci 1987;23:174-80.
2. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 1974;134:505-10.
3. Hook EW III, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983;249:1055-7.
4. Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315:1318-27.
5. Austrian R. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. J Infect Dis 1977;136:S38-S42.
6. Bolan G, Broome CV, Facklam RR, Plikaytis BD, Fraser DW, Schlech WF III. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med 1986;104:1-6.
7. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988;108:653-7.
8. Forrester HL, Jahnigen DW, LaForce FM. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med 1987;83:425-30.
9. Farr BM, Johnston L, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk. Arch Intern Med 1995;155:2336-40.
10. Shapiro ED, Clemens JD. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med 1984;101:325-30.
11. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
12. Ruben FL, Uhrin M. Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine. J Infect Dis 1985;151:845-9.
13. Hilleman MR, Carlson AJ, Jr, McLean AA, Vella PP, Weibel RE, Woodhour AF. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981;3(suppl):S31-S42.
14. Musher DM, Groover JE, Graviss EA, Baughn RE. The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis 1996;22: 165-7.
15. Sankilampi U, Honkanen PO, Bloigu A, Herva E, Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis 1996;173:387-93.
16. Hedlund JU, Kalin ME, Ortqvist AB, Henrichsen J. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Arch Intern Med 1994;154:1961-5.
17. Roghmann KJ, Tabloski PA, Bentley DW, Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol 1987;42:265-70.
18. Ammann AJ, Schiffman G, Austrian R. The antibody response to pneumococcal capsular polysaccharides in aged individuals. Proc Soc Exp Biol Med 1980;164:312-6.
19. Konradsen HB. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin Infect Dis 1995;21:616-20.